Comparing two antibiotics for COPD flare-ups
Treatments studied
Part of Lungs & breathing clinical trials.
This study compares two antibiotics, doxycycline and levofloxacin, to see which works better for treating COPD flare-ups. If you have a COPD exacerbation and haven't taken antibiotics recently, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with COPD and are currently having a flare-up.
- You are able to give written consent to participate.
- You have not taken any antibiotics in the past 4 weeks.
- You are not allergic to any of the study drugs.
- You do not have pneumonia or any other lung condition like asthma.
- You are not pregnant or breastfeeding, and you are not being treated for another active infection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a personalized approach to how long antibiotics are given for COPD flare-ups. It aims to see if matching antibiotic duration to each patient's needs is safe and effective, potentially avoiding unnecessary antibiotics.
This study looks at whether simple blood tests can help doctors decide if you need antibiotics and steroids for a COPD flare-up. Participating may help tailor your treatment and avoid unnecessary medications.
This study tests a new approach to reduce flare-ups (sudden worsening of symptoms) in people with COPD. If you've had frequent flare-ups, this trial may help you manage your condition better.
This study compares two medications, roflumilast and azithromycin, to see which is better at reducing COPD flare-ups (also called exacerbations) in people with severe COPD and chronic bronchitis. If it works, it could help you have fewer flare-ups and feel better day to day.
This study tests whether measuring two blood markers (MxA and CRP) can help doctors decide if antibiotics or antiviral drugs are needed for a COPD flare-up. It aims to reduce unnecessary antibiotic use while still treating infections effectively.
This trial compares two antibiotics, azithromycin and doxycycline, when given alongside a standard beta-lactam antibiotic to hospitalized adults with community-acquired pneumonia. It aims to see which combination works better and is safer.
Hear when a new COPD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.